Shaji K. Kumar, MD, on Multiple Myeloma: NCCN Guidelines Update

NCCN 2021 Virtual Annual Conference

Shaji K. Kumar, MD, of the Mayo Clinic Cancer Center, discusses the latest data on treating patients with multiple myeloma, including standard-of-care induction before stem cell transplant; the role of quadruplet induction; long-term results with the combination of daratumumab, lenalidomide, and dexamethasone in those who are ineligible for stem cell transplant; CAR T-cell engagers; and the need for more research on how immunotherapy fits in the sequence of treatments.

Shaji K. Kumar, MD, on Multiple Myeloma: NCCN Guidelines Update

Related Videos

Melinda L. Telli, MD, on HER2-Positive Breast Cancer: NCCN Guidelines Update

Mary F. Mulcahy, MD, and Crystal S. Denlinger, MD, on NCCN Guidelines Updates: Gastric and Esophageal Cancers

Susan M. Swetter, MD, on Molecular Testing for Cutaneous Melanoma

William J. Gradishar, MD, on Triple-Negative Breast Cancer: NCCN Guidelines Update

Gabrielle A. Zecha, PA-C, MHA, and Aaron Begue, MS, RN, NP-C, OCN: The Role of Advanced Practice Providers in Oncology Care

Meta-analysis Finds Liver Tumors May Be Resistant to Immunotherapy in Patients With Underlying Nonalcoholic Steatohepatitis

President Biden Issues Proclamation on National Cancer Control Month 2021

Low-Dose Tamoxifen for Reduction of Mammographic Density in Women Undergoing Breast Cancer Screening

Improving Survival for Patients With Stage II Pancreatic Cancer Chemotherapy Followed by Resection

Patients With NSCLC and Driver Mutations May Be More Likely to Present With Brain Metastasis at Diagnosis